12/10/2025
We are honored to announce Dr. Denis Fedorenko, MD, PhD, as a Keynote Speaker at SBMT 2026.
Dr. Fedorenko is widely recognized as a global leader in hematology, cellular therapy, and the advancement of autologous hematopoietic stem cell transplantation (AHSCT) for multiple sclerosis and autoimmune diseases. His pioneering work has reshaped treatment pathways, influenced global standards, and expanded what clinicians can expect from regenerative neuroimmunology.
With more than 200 scientific publications, multiple international awards from the European Hematology Association, and two decades of clinical innovation, Dr. Fedorenko continues to push the boundaries of science and patient care. His keynote will explore the future of AHSCT, long-term neurological outcomes, and the evolving role of cellular therapy in complex autoimmune disorders.
SBMT 2026 in Los Angeles will bring together the world’s leading researchers, physicians, engineers, and innovators. Dr. Fedorenko’s keynote will be a central moment for anyone shaping the next era of brain and spinal cord therapeutics.
Join us in welcoming Dr. Fedorenko to the SBMT 2026 stage:
Dr. Denis Fedorenko joins SBMT 2026 as Keynote Speaker, sharing groundbreaking advances in stem cell therapy for MS and autoimmune diseases.